Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Rizzo

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of Molecular and Cellular Cardiology|December 22, 2010
Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin IIAkira Takaguri, Heigoro Shirai, Keita Kimura, et al.
Journal of Extracellular Vesicles|September 18, 2020
Endothelial cell-derived extracellular vesicles alter vascular smooth muscle cell phenotype through high-mobility group box proteinsMichael J Boyer, Yayoi Kimura, Tomoko Akiyama, et al.
Clinical Science (London, England : 1979)|December 17, 2013
Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidaseTakehiko Takayanagi, Kevin J Crawford, Tomonori Kobayashi, et al.
Physiological Reviews|June 7, 2018
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and PathophysiologySteven J Forrester, George W Booz, Curt D Sigmund, et al.
Journal of Molecular and Cellular Cardiology|April 10, 2013
Volume overload induces differential spatiotemporal regulation of myocardial soluble guanylyl cyclase in eccentric hypertrophy and heart failureYuchuan Liu, A Ray Dillon, Michael Tillson, et al.
Hypertension (Dallas, Tex. : 1979)|January 11, 2023
Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin IIKeisuke Okuno, Keiichi Torimoto, Stephanie M Cicalese, et al.
Biomedical Microdevices|May 20, 2009
A physiologically realistic in vitro model of microvascular networksJenna M Rosano, Nazanin Tousi, Robert C Scott, et al.
Hypertension (Dallas, Tex. : 1979)|November 30, 2016
Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin IISteven J Forrester, Katherine J Elliott, Tatsuo Kawai, et al.
Circulation Research|February 4, 2012
A caveolae-targeted L-type Ca²+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractilityCatherine A Makarewich, Robert N Correll, Hui Gao, et al.
Journal of Cardiovascular Pharmacology|March 14, 2020
Transduction Efficiency of Adenovirus Vectors in Endothelial Cells and Vascular Smooth Muscle CellsNikita Mokhashi, Robert Y Choi, Stephanie Cicalese, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Molecular and Cellular Cardiology|December 22, 2010
Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin IIAkira Takaguri, Heigoro Shirai, Keita Kimura, et al.
Journal of Extracellular Vesicles|September 18, 2020
Endothelial cell-derived extracellular vesicles alter vascular smooth muscle cell phenotype through high-mobility group box proteinsMichael J Boyer, Yayoi Kimura, Tomoko Akiyama, et al.
Clinical Science (London, England : 1979)|December 17, 2013
Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidaseTakehiko Takayanagi, Kevin J Crawford, Tomonori Kobayashi, et al.
Physiological Reviews|June 7, 2018
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and PathophysiologySteven J Forrester, George W Booz, Curt D Sigmund, et al.
Journal of Molecular and Cellular Cardiology|April 10, 2013
Volume overload induces differential spatiotemporal regulation of myocardial soluble guanylyl cyclase in eccentric hypertrophy and heart failureYuchuan Liu, A Ray Dillon, Michael Tillson, et al.
Hypertension (Dallas, Tex. : 1979)|January 11, 2023
Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin IIKeisuke Okuno, Keiichi Torimoto, Stephanie M Cicalese, et al.
Biomedical Microdevices|May 20, 2009
A physiologically realistic in vitro model of microvascular networksJenna M Rosano, Nazanin Tousi, Robert C Scott, et al.
Hypertension (Dallas, Tex. : 1979)|November 30, 2016
Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin IISteven J Forrester, Katherine J Elliott, Tatsuo Kawai, et al.
Circulation Research|February 4, 2012
A caveolae-targeted L-type Ca²+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractilityCatherine A Makarewich, Robert N Correll, Hui Gao, et al.
Journal of Cardiovascular Pharmacology|March 14, 2020
Transduction Efficiency of Adenovirus Vectors in Endothelial Cells and Vascular Smooth Muscle CellsNikita Mokhashi, Robert Y Choi, Stephanie Cicalese, et al.
Pageof 5